| Element List | Explanation |
|---|---|
| Introduction | Saudi Chemical Company Holding (SCCH), through its pharmaceutical sector represented by AJA Pharmaceutical Industries Ltd. (AJA Pharma), announced signing MOU with Bioventure FZ-LLC, a subsidiary of GlobalOne Healthcare Holding (GHH), for potential licensing and supply of new additional selected pharmaceutical products in the Middle East region in the Saudi Export stand during Arab Health Exhibition 2023. |
| Memorandum Signing Date | 2023-02-01 Corresponding to 1444-07-10 |
| Counterparty | Bioventure FZ-LLC, a subsidiary of GlobalOne Healthcare Holding (GHH) |
| Memorandum Subject | The MOU with Bioventure will focus on developing a variety of delivery forms, including complex to-develop formulations, including diabetes, oncology and biosimilars, therapeutic categories that are forecasted to be among the largest and fastest-growing within the global pharma sector over the coming years. |
| Memorandum Duration | One year |
| Related Parties | None |
| Financial Impact | The financial impact of this MOU will be determined later. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.